Fresenius Medical Care (FMS) Stock Forecast & Price Target

$22.81 +0.33 (+1.47%)

(As of 12/20/2024 05:31 PM ET)

Fresenius Medical Care - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 4 Analyst Ratings

Sell
1

Hold
2

Buy
1

Based on 4 Wall Street analysts who have issued ratings for Fresenius Medical Care in the last 12 months, the stock has a consensus rating of "Hold." Out of the 4 analysts, 1 has given a sell rating, 2 have given a hold rating, and 1 has given a buy rating for FMS.

Consensus Price Target

$24.30
6.53% Upside

According to the 4 analysts' twelve-month price targets for Fresenius Medical Care, the average price target is $24.30. The highest price target for FMS is $25.60, while the lowest price target for FMS is $23.00. The average price target represents a forecasted upside of 6.53% from the current price of $22.81.

Get the Latest News and Ratings for FMS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Fresenius Medical Care and its competitors.

FMS Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$24.30	$24.30	$22.00	$17.85
Forecasted Upside	6.53% Upside	10.56% Upside	8.64% Upside	-14.55% Downside
Consensus Rating	Hold	Hold	Hold	Hold

AI breakthrough about to upend industry (Ad)

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

I urge you to watch it now.

FMS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

FMS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Fresenius Medical Care Stock vs. The Competition

Type	Fresenius Medical Care	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.81	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	6.53% Upside	25,828.55% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent FMS News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/2/2024	Bank of America 3 of 5 stars		Upgrade	Underperform ➝ Neutral
11/6/2024	Berenberg Bank 2 of 5 stars	V. Lambert Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$25.60	+25.98%
10/7/2024	Truist Financial 2 of 5 stars		Boost Target	Hold ➝ Hold	$22.00 ➝ $23.00	+10.79%
1/8/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Equal Weight ➝ Underweight
11/24/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Reduce ➝ Hold
11/17/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
9/13/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Sell ➝ Neutral
8/1/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral
7/12/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
4/28/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Sell ➝ Hold
3/7/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform
1/2/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Underperform	$14.00 ➝ $11.70	-28.40%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:22 PM ET.

FMS Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Fresenius Medical Care is $24.30, with a high forecast of $25.60 and a low forecast of $23.00.
: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care in the last year. There is currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
: According to analysts, Fresenius Medical Care's stock has a predicted upside of 6.53% based on their 12-month stock forecasts.
: Over the previous 90 days, Fresenius Medical Care's stock had 1 upgrade by analysts.
: Fresenius Medical Care has been rated by research analysts at Bank of America, Berenberg Bank, and Truist Financial in the past 90 days.
: Analysts like Fresenius Medical Care less than other "medical" companies. The consensus rating for Fresenius Medical Care is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how FMS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

AI breakthrough about to upend industry (Ad)

I urge you to watch it now.

This page (NYSE:FMS) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care (FMS) Stock Forecast & Price Target